Codexis Inc (CDXS) Stock Price, Quote & News - Mboum

Company Profile

Codexis, Inc. provides technology solutions for therapeutics manufacturing, leveraging its proprietary CodeEvolver technology platform to discover, develop, enhance, and commercialize novel enzymes in the United States, Canada, Latin America, Europe, the Middle East, Africa, Australia, New Zealand, Southeast Asia, and China. The company develops its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. It has a license...

Industry: Biotechnology

Sector: Healthcare

Phone: 650 421 8100

Website: www.codexis.com

Address:

200 Penobscot Drive, Redwood City, United States

Fingerlickengood Apr. 20 at 3:47 PM

$CDXS @Kanate123

0 · Reply

Fingerlickengood Apr. 20 at 3:32 PM

$CDXS Maybe today? 😀

0 · Reply

Jiggitus23 Apr. 20 at 2:26 PM

$CDXS on one hand, I fully expect this to plummet to 99 cents. On the other hand, this looks like a build up to a very beneficial explosion to our benefit. . Regardless I'm

1 · Reply

Rolbox Apr. 20 at 2:22 PM

$CDXS lets gooo

0 · Reply

Fingerlickengood Apr. 19 at 4:17 PM

$CDXS This coming week could be BIG.

1 · Reply

Alleyesonme44 Apr. 17 at 11:29 PM

$BCHMF $CDXS long standing, close collaboration…IMO…it’s hard to imagine a scenario where Bachem isn’t using Codexis proprietary technology to manufacture oligonucleotides…$CDXS news imminent…I can’t see it any other way…thanks for sharing fingerlick…up up and away!

0 · Reply

Fingerlickengood Apr. 17 at 8:37 PM

$CDXS $BCHMF https://www.worldpharmaceuticals.net/pressreleases/efficient-large-scale-sirna-manufacturing-enzymatic-ligation-of-short-rna-fragments/ https://www.linkedin.com/feed/update/urn:li:ugcPost:7450906105779712000/?originTrackingId=LJMFT2JwRB6RZBKy0nlM4g%3D%3D

0 · Reply

Fingerlickengood Apr. 17 at 7:43 PM

$CDXS Will be interesting to see it close, news Monday could squeeze shorts bad. Contract, Partnership(s), Eco Synthesis Licensing, and FDA AMT Designation news is ALL coming. I know what I know and the shorts are gonna get fried!

0 · Reply

djohndjohn Apr. 17 at 7:24 PM

$CDXS sadly someone is holding this down. Could be a low ball offer?

0 · Reply

Fingerlickengood Apr. 17 at 4:46 PM

$CDXS opaleye averaged at $2.83/shr, I have a feeling that is the magic number to break here!

0 · Reply

Latest News on CDXS

Codexis Reports Fourth Quarter and Fiscal Year 2025 Financial Results

Mar 11, 2026, 4:05 PM EDT - 5 weeks ago

Codexis Reports Fourth Quarter and Fiscal Year 2025 Financial Results

Codexis signs agreement to manufacture 50 g siRNA using its ECO Synthesis® Manufacturing Platform

Mar 4, 2026, 10:06 AM EST - 6 weeks ago

Codexis signs agreement to manufacture 50 g siRNA using its ECO Synthesis® Manufacturing Platform

Codexis to Report Fourth Quarter and Fiscal Year 2025 Financial Results on March 11

Feb 25, 2026, 9:00 AM EST - 7 weeks ago

Codexis to Report Fourth Quarter and Fiscal Year 2025 Financial Results on March 11

Codexis Achieves ISO 9001:2015 Certification

Feb 10, 2026, 9:00 AM EST - 2 months ago

Codexis Achieves ISO 9001:2015 Certification

Codexis Expands Reach of the ECO Synthesis® Manufacturing Platform through a Signed Evaluation Agreement with Axolabs for Oligonucleotide Therapeutics

Jan 7, 2026, 9:00 AM EST - 3 months ago

Codexis Expands Reach of the ECO Synthesis® Manufacturing Platform through a Signed Evaluation Agreement with Axolabs for Oligonucleotide Therapeutics

Codexis Announces Signing of Lease for GMP Manufacturing Facility

Nov 10, 2025, 9:00 AM EST - 5 months ago

Codexis Announces Signing of Lease for GMP Manufacturing Facility

Codexis and Nitto Denko Avecia Enter Evaluation Agreement to Explore Codexis's ECO Synthesis® Manufacturing Platform for Therapeutic siRNA Manufacturing

Oct 29, 2025, 9:58 AM EDT - 6 months ago

Codexis and Nitto Denko Avecia Enter Evaluation Agreement to Explore Codexis's ECO Synthesis® Manufacturing Platform for Therapeutic siRNA Manufacturing

Codexis to Report Third Quarter 2025 Financial Results on November 6

Oct 23, 2025, 7:05 AM EDT - 6 months ago

Codexis to Report Third Quarter 2025 Financial Results on November 6

Codexis to Participate in Cantor Global Healthcare Conference

Aug 28, 2025, 9:00 AM EDT - 8 months ago

Codexis to Participate in Cantor Global Healthcare Conference

Codexis Reports Second Quarter 2025 Financial Results

Aug 13, 2025, 4:05 PM EDT - 8 months ago

Codexis Reports Second Quarter 2025 Financial Results

Codexis to Report Second Quarter 2025 Financial Results on August 13

Jul 30, 2025, 4:05 PM EDT - 9 months ago

Codexis to Report Second Quarter 2025 Financial Results on August 13

Codexis' Landmark Presentations at TIDES USA Highlight Reproducibility and Process Simplification of the ECO Synthesis Platform for Manufacturing siRNA

May 22, 2025, 7:00 AM EDT - 11 months ago

Codexis' Landmark Presentations at TIDES USA Highlight Reproducibility and Process Simplification of the ECO Synthesis Platform for Manufacturing siRNA

Codexis to Participate in Jefferies Global Healthcare Conference

May 21, 2025, 4:05 PM EDT - 11 months ago

Codexis to Participate in Jefferies Global Healthcare Conference

Codexis Reports First Quarter 2025 Financial Results

May 14, 2025, 4:05 PM EDT - 1 year ago

Codexis Reports First Quarter 2025 Financial Results

Codexis Announces Six Presentations Featuring the ECO Synthesis Platform at TIDES USA Annual Meeting

May 7, 2025, 7:00 AM EDT - 1 year ago

Codexis Announces Six Presentations Featuring the ECO Synthesis Platform at TIDES USA Annual Meeting

Codexis to Report First Quarter 2025 Financial Results on May 14

Apr 30, 2025, 4:05 PM EDT - 1 year ago

Codexis to Report First Quarter 2025 Financial Results on May 14

Codexis Announces Byron Dorgan to Retire from Board of Directors

Apr 9, 2025, 5:00 PM EDT - 1 year ago

Codexis Announces Byron Dorgan to Retire from Board of Directors

Codexis Announces New Employment Inducement Grants

Mar 7, 2025, 4:05 PM EST - 1 year ago

Codexis Announces New Employment Inducement Grants

Codexis to Report Fourth Quarter and Fiscal Year 2024 Financial Results on February 27th

Feb 13, 2025, 4:05 PM EST - 1 year ago

Codexis to Report Fourth Quarter and Fiscal Year 2024 Financial Results on February 27th

Codexis Appoints Arthur Levin, PhD, to Strategic Advisory Board

Feb 6, 2025, 4:05 PM EST - 1 year ago

Codexis Appoints Arthur Levin, PhD, to Strategic Advisory Board

Codexis Appoints Christos Richards to Board of Directors

Jan 16, 2025, 4:05 PM EST - 1 year ago

Codexis Appoints Christos Richards to Board of Directors

Codexis to Participate in Piper Sandler 36th Annual Healthcare Conference

Nov 19, 2024, 4:05 PM EST - 1 year ago

Codexis to Participate in Piper Sandler 36th Annual Healthcare Conference

Codexis Unveils Pioneering Enzymatic Synthesis Data to Enable the Future Manufacturing of RNAi Therapeutics

Nov 14, 2024, 4:05 PM EST - 1 year ago

Codexis Unveils Pioneering Enzymatic Synthesis Data to Enable the Future Manufacturing of RNAi Therapeutics

Codexis Announces Appointment of Raymond De Vré, PhD, to Board of Directors

Nov 12, 2024, 4:05 PM EST - 1 year ago

Codexis Announces Appointment of Raymond De Vré, PhD, to Board of Directors

Codexis TIDES Europe Presentations to Feature Next Step in Evolution of Enzymatic Synthesis for RNAi Therapeutics

Nov 11, 2024, 4:05 PM EST - 1 year ago

Codexis TIDES Europe Presentations to Feature Next Step in Evolution of Enzymatic Synthesis for RNAi Therapeutics

Codexis to Participate in Upcoming Healthcare Conferences

Nov 4, 2024, 4:05 PM EST - 1 year ago

Codexis to Participate in Upcoming Healthcare Conferences

Codexis Announces Three siRNA Manufacturing Data Presentations at TIDES Europe Annual Meeting

Oct 24, 2024, 4:05 PM EDT - 1 year ago

Codexis Announces Three siRNA Manufacturing Data Presentations at TIDES Europe Annual Meeting

Codexis to Report Third Quarter 2024 Financial Results on October 31

Oct 10, 2024, 4:05 PM EDT - 1 year ago

Codexis to Report Third Quarter 2024 Financial Results on October 31

Codexis Increases Cash Reserves and Enhances Management Team to Fuel Growth of Company

Oct 2, 2024, 4:05 PM EDT - 1 year ago

Codexis Increases Cash Reserves and Enhances Management Team to Fuel Growth of Company

Codexis Licenses Genomics Life Science Enzyme Portfolio to Alphazyme LLC, part of Maravai LifeSciences

Oct 1, 2024, 7:05 AM EDT - 1 year ago

Codexis Licenses Genomics Life Science Enzyme Portfolio to Alphazyme LLC, part of Maravai LifeSciences

Codexis to Participate in Enzymatic Synthesis Presentations at RNA Leaders Annual Meeting

Aug 20, 2024, 4:05 PM EDT - 1 year ago

Codexis to Participate in Enzymatic Synthesis Presentations at RNA Leaders Annual Meeting

Codexis Publishes FY2023 Sustainability Disclosures

Aug 15, 2024, 4:05 PM EDT - 1 year ago

Codexis Publishes FY2023 Sustainability Disclosures

Codexis to Report Second Quarter 2024 Financial Results on August 8

Jul 18, 2024, 4:05 PM EDT - 1 year ago

Codexis to Report Second Quarter 2024 Financial Results on August 8

Codexis Finalizes Purchase Agreement with Crosswalk Therapeutics for Gene Therapy Assets

Jul 1, 2024, 4:05 PM EDT - 1 year ago

Codexis Finalizes Purchase Agreement with Crosswalk Therapeutics for Gene Therapy Assets

Codexis to Participate in TD Cowen 2nd Annual Sustainability Week

May 20, 2024, 4:05 PM EDT - 2 years ago

Codexis to Participate in TD Cowen 2nd Annual Sustainability Week

Codexis Presents Groundbreaking Enzymatic Synthesis Data at TIDES USA Annual Meeting

May 14, 2024, 6:00 AM EDT - 2 years ago

Codexis Presents Groundbreaking Enzymatic Synthesis Data at TIDES USA Annual Meeting

Codexis to Report First Quarter 2024 Financial Results on May 2

Apr 18, 2024, 4:05 PM EDT - 2 years ago

Codexis to Report First Quarter 2024 Financial Results on May 2

Codexis Appoints Carole Cobb, MBA, to Strategic Advisory Board

Apr 11, 2024, 7:05 AM EDT - 2 years ago

Codexis Appoints Carole Cobb, MBA, to Strategic Advisory Board

Codexis Reports Fourth Quarter and Fiscal Year 2023 Financial Results

Feb 28, 2024, 4:05 PM EST - 2 years ago

Codexis Reports Fourth Quarter and Fiscal Year 2023 Financial Results

Codexis Enters Exclusive Licensing Agreement for Newly Engineered Double-Stranded DNA Ligase with Roche

Feb 26, 2024, 4:05 PM EST - 2 years ago

Codexis Enters Exclusive Licensing Agreement for Newly Engineered Double-Stranded DNA Ligase with Roche

Codexis to Participate in TD Cowen 44th Annual Health Care Conference

Feb 26, 2024, 8:05 AM EST - 2 years ago

Codexis to Participate in TD Cowen 44th Annual Health Care Conference

Codexis Announces Appointment of Masad Damha, PhD, and Jim Lalonde, PhD, to Strategic Advisory Board

Feb 20, 2024, 8:05 AM EST - 2 years ago

Codexis Announces Appointment of Masad Damha, PhD, and Jim Lalonde, PhD, to Strategic Advisory Board

Codexis to Report Fourth Quarter and Fiscal Year 2023 Financial Results on February 28

Feb 14, 2024, 4:05 PM EST - 2 years ago

Codexis to Report Fourth Quarter and Fiscal Year 2023 Financial Results on February 28

Codexis Secures $40 Million in Strategic Financing Deal with Innovatus Capital Partners to Further Strengthen Cash Position Ahead of Key Milestones

Feb 13, 2024, 4:05 PM EST - 2 years ago

Codexis Secures $40 Million in Strategic Financing Deal with Innovatus Capital Partners to Further Strengthen Cash Position Ahead of Key Milestones

seqWell and Codexis to Unveil Engineered Transposase Enzyme for Genomics Applications at AGBT General Meeting

Feb 1, 2024, 4:05 PM EST - 2 years ago

seqWell and Codexis to Unveil Engineered Transposase Enzyme for Genomics Applications at AGBT General Meeting

Codexis Announces Purchase Agreement with Nestlé Health Science for CDX-7108

Dec 27, 2023, 8:30 AM EST - 2 years ago

Codexis Announces Purchase Agreement with Nestlé Health Science for CDX-7108

Codexis and Aldevron Enter Exclusive Licensing Agreement for Codex® HiCap RNA Polymerase

Dec 13, 2023, 4:06 PM EST - 2 years ago

Codexis and Aldevron Enter Exclusive Licensing Agreement for Codex® HiCap RNA Polymerase

Codexis Announces Achievement of Gram-scale Synthesis with its ECO Synthesis™ Platform

Dec 13, 2023, 4:05 PM EST - 2 years ago

Codexis Announces Achievement of Gram-scale Synthesis with its ECO Synthesis™ Platform

Codexis KOL Event Highlights Significant Need for an Enzymatic Route of Synthesis in RNAi Therapeutics Manufacturing

Dec 11, 2023, 7:05 AM EST - 2 years ago

Codexis KOL Event Highlights Significant Need for an Enzymatic Route of Synthesis in RNAi Therapeutics Manufacturing

Codexis to Host Virtual KOL Event on its ECO Synthesis™ Platform and the Future of RNAi Therapeutics Manufacturing on December 8, 2023

Nov 28, 2023, 4:05 PM EST - 2 years ago

Codexis to Host Virtual KOL Event on its ECO Synthesis™ Platform and the Future of RNAi Therapeutics Manufacturing on December 8, 2023

Fingerlickengood Apr. 20 at 3:47 PM

$CDXS @Kanate123

0 · Reply

Fingerlickengood Apr. 20 at 3:32 PM

$CDXS Maybe today? 😀

0 · Reply

Jiggitus23 Apr. 20 at 2:26 PM

$CDXS on one hand, I fully expect this to plummet to 99 cents. On the other hand, this looks like a build up to a very beneficial explosion to our benefit. . Regardless I'm

1 · Reply

Rolbox Apr. 20 at 2:22 PM

$CDXS lets gooo

0 · Reply

Fingerlickengood Apr. 19 at 4:17 PM

$CDXS This coming week could be BIG.

1 · Reply

Alleyesonme44 Apr. 17 at 11:29 PM

$BCHMF $CDXS long standing, close collaboration…IMO…it’s hard to imagine a scenario where Bachem isn’t using Codexis proprietary technology to manufacture oligonucleotides…$CDXS news imminent…I can’t see it any other way…thanks for sharing fingerlick…up up and away!

0 · Reply

Fingerlickengood Apr. 17 at 8:37 PM

$CDXS $BCHMF https://www.worldpharmaceuticals.net/pressreleases/efficient-large-scale-sirna-manufacturing-enzymatic-ligation-of-short-rna-fragments/ https://www.linkedin.com/feed/update/urn:li:ugcPost:7450906105779712000/?originTrackingId=LJMFT2JwRB6RZBKy0nlM4g%3D%3D

0 · Reply

Fingerlickengood Apr. 17 at 7:43 PM

$CDXS Will be interesting to see it close, news Monday could squeeze shorts bad. Contract, Partnership(s), Eco Synthesis Licensing, and FDA AMT Designation news is ALL coming. I know what I know and the shorts are gonna get fried!

0 · Reply

djohndjohn Apr. 17 at 7:24 PM

$CDXS sadly someone is holding this down. Could be a low ball offer?

0 · Reply

Fingerlickengood Apr. 17 at 4:46 PM

$CDXS opaleye averaged at $2.83/shr, I have a feeling that is the magic number to break here!

0 · Reply

Fingerlickengood Apr. 17 at 4:45 PM

$CDXS Love these pull backs, shorts scrambling to cover as institions are buying hand over fist!

0 · Reply

Fingerlickengood Apr. 17 at 4:06 PM

$CDXS WELL SAID sir!

0 · Reply

Alleyesonme44 Apr. 17 at 4:04 PM

$CDXS as we see with other corps, the inevitability here is what could send the valuation into the billions prior to revenue capture. New, disruptive, PROPRIETARY!…high hopes…10..20..30..40$$$…rare cases this happens quickly…all three boxes are checked…..don’t forget about the fourth box…VERIFIED!…through the MERK deal..

0 · Reply

Fingerlickengood Apr. 17 at 4:03 PM

$CDXS Where did @KUMO2026 go? What a donkey!

0 · Reply

Fingerlickengood Apr. 17 at 3:48 PM

$CDXS ANY fraction of a forecasted siRNA /oligo manufacturing market estimated to be $20B+ in the next 3-5 years, will inevevitably make this company worth $2B++. At approximately 100M shares outstanding, easy $20++ /share by patiently buying an holding as contracting and licensing deals are made! Enjoy the ride!

0 · Reply

Rolbox Apr. 17 at 3:44 PM

0 · Reply

nlstbro Apr. 17 at 3:36 PM

$CDXS $2.72 + will B!

0 · Reply

Fingerlickengood Apr. 17 at 3:31 PM

$CDXS This next leg up will be EPIC!

0 · Reply

AnomalyDetective Apr. 17 at 3:23 PM

$BDTX (Week 16 MDA) breakout continues sharply higher with new Week 17 MDA picks out for members. 💥Extending the count to 363 weeks with at least 1 pick gaining over 10% in less than a week in my long term study with up to 84 breakout picks released daily at http://vmbreakouts.com 💥 Watch for small cap #biotech #crypto to keep up the rally after #oil energy excitement cools. Lot of room to run in $BDTX $CDXS and many prior breakout picks shared previously and here: http://top.vmbreakouts.com

0 · Reply

Fingerlickengood Apr. 17 at 2:19 PM

$CDXS Bear trap....watch out! $3.00 closing price today?!

0 · Reply

Fingerlickengood Apr. 17 at 2:16 PM

$CDXS Did you notice this part....it comes 'fully built-out'

0 · Reply

Fingerlickengood Apr. 17 at 2:15 PM

$CDXS $NVS $BCHMF $ALNY As of this am, it looks like it is up and running! https://www.linkedin.com/company/codexis/posts/?feedView=all

0 · Reply